Dyspnoea after AZD6140: safety first?
Serebruany
Victor L
VL
D000241:Adenosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D017322:Clinical Trials, Phase II as Topic; D004417:Dyspnea / Q000139:chemically induced*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D000077486:Ticagrelor
D010975:Platelet Aggregation Inhibitors; D000077486:Ticagrelor; D000241:Adenosine